169 related articles for article (PubMed ID: 8182520)
1. S 12340: a potent inhibitor of the oxidative modification of low-density lipoprotein in vitro and ex vivo in WHHL rabbits.
Breugnot C; Privat S; Guillonneau C; Regnier G; Bouzom F; Vilaine JP; Lenaers A
J Pharmacol Exp Ther; 1994 May; 269(2):515-20. PubMed ID: 8182520
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant activity of piperlactam S: prevention of copper-induced LDL peroxidation and amelioration of free radical-induced oxidative stress of endothelial cells.
Tsai JY; Chou CJ; Chen CF; Chiou WF
Planta Med; 2003 Jan; 69(1):3-8. PubMed ID: 12567271
[TBL] [Abstract][Full Text] [Related]
3. In vitro and ex vivo inhibition of the modification of low-density lipoprotein by indapamide.
Breugnot C; Iliou JP; Privat S; Robin F; Vilaine JP; Lenaers A
J Cardiovasc Pharmacol; 1992 Sep; 20(3):340-7. PubMed ID: 1279277
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin inhibits copper-induced oxidation of low density lipoprotein.
Sakuma S; Fujimoto Y; Gohda Y; Fujita T
Res Commun Mol Pathol Pharmacol; 2000; 107(5-6):397-406. PubMed ID: 11589366
[TBL] [Abstract][Full Text] [Related]
5. Antioxidants suppress plasma levels of lectinlike oxidized low-density lipoprotein receptor-ligands and reduce atherosclerosis in watanabe heritable hyperlipidemic rabbits.
Oka K; Yasuhara M; Suzumura K; Tanaka K; Sawamura T
J Cardiovasc Pharmacol; 2006 Oct; 48(4):177-83. PubMed ID: 17086097
[TBL] [Abstract][Full Text] [Related]
6. [The effect of vitamin C in oxidative modification of low-density lipoprotein induced by macrophage and copperion].
Chen Y; Yang Q; Yang Y; Zhang X
Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):25-9. PubMed ID: 11955344
[TBL] [Abstract][Full Text] [Related]
7. A critical overview of the chemistry of copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxides, alpha-tocopherol, thiols, and ceruloplasmin.
Burkitt MJ
Arch Biochem Biophys; 2001 Oct; 394(1):117-35. PubMed ID: 11566034
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on the effect of low-dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits.
Kleinveld HA; Demacker PN; Stalenhoef AF
Arterioscler Thromb; 1994 Aug; 14(8):1386-91. PubMed ID: 8049202
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of 4,6-di-tert-butyl-2,3-dihydro-5-benzofuranols as a novel series of antiatherogenic antioxidants.
Tamura K; Kato Y; Ishikawa A; Kato Y; Himori M; Yoshida M; Takashima Y; Suzuki T; Kawabe Y; Cynshi O; Kodama T; Niki E; Shimizu M
J Med Chem; 2003 Jul; 46(14):3083-93. PubMed ID: 12825946
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant properties of two novel 2-biphenylmorpholine compounds (EP2306 and EP2302) in vitro and in vivo.
Tavridou A; Manolopoulos VG
Eur J Pharmacol; 2004 Nov; 505(1-3):213-21. PubMed ID: 15556155
[TBL] [Abstract][Full Text] [Related]
11. Effects of resveratrol on oxidative modification of human low density lipoprotein.
Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
[TBL] [Abstract][Full Text] [Related]
12. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
[TBL] [Abstract][Full Text] [Related]
13. Antioxidant effect of probucol on RO2*/O2(*-)-induced peroxidation of human low-density lipoproteins.
Bonnefont-Rousselot D; Segaud C; Jore D; Delattre J; Gardès-Albert M
Radiat Res; 1999 Mar; 151(3):343-53. PubMed ID: 10073673
[TBL] [Abstract][Full Text] [Related]
14. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
[TBL] [Abstract][Full Text] [Related]
15. [Inhibition effect of soybean isoflavones on the oxidative modification of low-density lipoprotein].
Yan X; Gu J; Sun C; Liu D
Wei Sheng Yan Jiu; 2001 Nov; 30(6):346-9. PubMed ID: 12561616
[TBL] [Abstract][Full Text] [Related]
16. The in vitro and ex vivo antioxidant properties, and hypolipidemic activity of CGP 2881.
Feldman DL; Mogelesky TC; Sharif R; Sawyer WK; Jeune M; Hu CW; Leonards KS; Prescott MF
Atherosclerosis; 1999 Jun; 144(2):343-55. PubMed ID: 10407495
[TBL] [Abstract][Full Text] [Related]
17. Angelica protects the human vascular endothelial cell from the effects of oxidized low-density lipoprotein in vitro.
Xiaohong Y; Jing-Ping OY; Shuzheng T
Clin Hemorheol Microcirc; 2000; 22(4):317-23. PubMed ID: 11081469
[TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite-mediated oxidative modification of low-density lipoprotein by aqueous extracts of cigarette smoke and the preventive effect of fluvastatin.
Yamaguchi Y; Matsuno S; Kagota S; Haginaka J; Kunitomo M
Atherosclerosis; 2004 Feb; 172(2):259-65. PubMed ID: 15019535
[TBL] [Abstract][Full Text] [Related]
19. Effects of ebselen and probucol on oxidative modifications of lipid and protein of low density lipoprotein induced by free radicals.
Noguchi N; Gotoh N; Niki E
Biochim Biophys Acta; 1994 Jul; 1213(2):176-82. PubMed ID: 8025128
[TBL] [Abstract][Full Text] [Related]
20. Dipyridamole inhibits the oxidative modification of low density lipoprotein.
Selley ML; Czeti AL; McGuiness JA; Ardlie NG
Atherosclerosis; 1994 Nov; 111(1):91-7. PubMed ID: 7840817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
